The cancer microenvironment and interaction between cancer and stromal cells play critical roles in tumor development and progression. The molecular features of cancer stroma are less well understood than those of cancer cells. Cancer-associated stromal fibroblasts are the predominant component of stroma associated with colon cancer and its functions remain unclear. Fibroblast cell cultures were established from metastatic colon cancer in liver, liver away from the metastatic lesions, and skin from three patients with metastatic colorectal cancer. We generated expression profiles of cancer-associated fibroblasts using oligochip arrays and compared them to those of uninvolved fibroblasts. The conditioned media from the cancer-associated fibroblast cultures enhanced proliferation of colon cancer cell line HCT116 to a greater extent than cultures from uninvolved fibroblasts. In microarray expression analysis, cancer-associated fibroblasts clustered tightly into one group and skin fibroblasts into another. Approximately 170 of 22 000 genes were upregulated in cancer-associated fibroblasts (fold change42, Po0.05) as compared to skin fibroblasts, including many genes encoding cell adhesion molecules, growth factors, and COX2. By immunohistochemistry in-vivo, we confirmed COX2 and TGFB2 expression in cancer-associated fibroblasts in metastatic colon cancer. The distinct molecular expression profiles of cancerassociated fibroblasts in colon cancer metastasis support the notion that these fibroblasts form a favorable microenvironment for cancer cells.
Introduction
Cancer is subject to a unique microenvironment, composed of cancer cells, cancer-associated stromal fibroblasts (CAFs), endothelial cells, inflammatory cells, and abundant extracellular matrix (Hanahan and Weinberg, 2000; Matrisian et al., 2001) . It has been hypothesized that these components are functionally organized to promote survival of cancer cells in the host and generate a favorable microenvironment for cancer cells in both primary and metastatic sites (Liotta and Kohn, 2001 ). The 'seed and soil hypothesis' in cancer proposed by Paget (1889) over a century ago emphasized the tumor microenvironment and tumor-host crosstalk in organ-specific cancer metastasis and the 'seed-soil' compatibility contributing to the establishment of metastasis and colonization of cancer cells (Mu¨ller et al., 2001) . However, molecular features of the 'soil' are less well understood than those of the 'seed', and understanding the 'soil' is now an important issue in cancer research and therapy.
Two major components of the cancer-associated stroma are endothelial cells and fibroblasts. Angiogenesis and anti-angiogenesis strategies targeting endothelial cells have been established by Folkman (1985) . The fibroblasts are also thought to contribute to cancer development, to treatment resistance, and to invasion and metastasis (Liotta and Kohn, 2001; Tlsty, 2001 ). Myofibroblasts, a specialized type of fibroblast, are one of the predominant cell types in the cancer stroma (Schmitt-Gra¨ff et al., 1994) . In addition to their role in creating the structural matrix around cancer cells, myofibroblasts have been thought to be endowed with enhanced activities that promote the growth of nearby cancer cells (Powell et al., 1999; Elenbass and Weinberg, 2001) . Tumor stroma formation shares many important properties with wound healing, but wound healing is usually self-limited while the growth of tumors and tumor stroma is not. In fact, tumor stroma has been compared to a 'wound that does not heal' (Dvorak, 1986) . Desmoplasia is a characteristic pathologic feature of many kinds of human solid tumors including pancreatic, colon, and prostate cancers, but it is not clear whether the desmoplastic reaction is a mechanism that stimulates tumor growth or represents a host defense mechanism to restrict tumor expansion (Elenbass and Weinberg, 2001; Dvorak, 1986) .
Colorectal cancer is the second most common cause of cancer death in western countries, and metastasis to the liver leads to much of the mortality in these patients. In this study, we focused on the CAFs by establishing primary fibroblast cultures from patients with metastatic colon cancer to the liver and characterized their growthpromoting effects on colon cancer cells in vitro. In order to better understand the underlying mechanisms at the molecular level, we generated genome-wide expression molecular profiles of CAFs and compared them to the profiles of uninvolved fibroblasts.
Results

Characterization of fibroblast cultures from metastatic colon cancers in the liver
We established fibroblast cultures from three sources in three patients with metastatic colorectal cancer in the liver. We confirmed the absence of epithelial cells or cancer cells by sensitive reverse transcriptase-polymerase chain reaction (RT-PCR) of the highly epitheliumspecific markers, cytokeratin-19 and -20. RT-PCR for vimentin demonstrated that all of the cultures were composed of fibroblasts (data not shown). Immunofluorescent staining for a-smooth muscle actin (aSMA) showed that all fibroblasts expressed aSMA (Figure 1 ), confirming that they were myofibroblasts (SchmittGra¨ff et al., 1994) .
To further characterize the fibroblast cultures and compare their putative effect on cancer cell growth, we generated conditioned media after culture in low-serum medium. The colon cancer cell line HCT116 was incubated in conditioned medium and effects on its proliferation and growth pattern were analyzed. In the control medium, HCT116 cells formed spheroids, while conditioned medium from all fibroblasts dramatically prevented spheroid formation (Figure 2a ). This negative effect on spheroid formation tended to be stronger with conditioned medium from CAFs than skin fibroblasts and liver fibroblasts. A growth-promoting effect was observed with conditioned medium and included an increased overall cell number ( Figure 2b ) and increased BrdU cell incorporation (Figure 2c ). The enhanced proliferation of the colon cancer cell line after conditioned medium treatment in vitro as measured by both cell number and BrdU incorporation occurred in the following order; skin fibroblasts oliver fibroblasts oCAFs. The growth-promoting effect was significantly greater with conditioned medium from CAFs as compared with the conditioned medium from skin fibroblasts (P ¼ 0.0134 for cell number and P ¼ 0.0280 for BrdU incorporation, two-tailed). Even though there was a clear trend towards increased cell number with the conditioned medium from CAFs as compared with the conditioned medium from fibroblasts of the normal liver away from cancer, there were no significant differences in the growth-promoting effect between them (P ¼ 0.0522 for cell number and P ¼ 0.0736 for BrdU incorporation, two-tailed).
Expression profiles and clustering of fibroblasts
The expression profiles of fibroblasts derived from the metastatic cancers, from unaffected liver tissue, and from skin were compared using the genome-wide oligomicroarrays, HG-U133A. All three CAFs clustered tightly into one group and all three skin fibroblasts into another, suggesting that CAFs as well as skin fibroblasts are homogeneous and CAFs differ from skin fibroblasts (Figure 3 ). Liver fibroblasts not derived from the cancer were more heterogeneous in their expression pattern. A total of 170 genes among the approximately 22 000 we screened were up-regulated specifically in CAFs (fold change 42, Po0.05) compared to skin fibroblasts, some of which are listed in Table 1 . The up-regulated genes included many adhesion molecules (VCAM1, ICAM1, desmoglein2, K-cadherin, N-cadherin), extracellular matrix/extracellular matrix remodeling molecules (proteoglycan1, COL4A1, COL6A2, procollagen-lysin hydrogenese), and proteases/protease inhibitors (tissue plasminogen activator, plasminogen activator inhibitor type1, tissue factor). Importantly, multiple paracrine/ autocrine growth factors (PDGFA, FGF1, IGFBP7, IGFBP5, CTGF, PLAB, VEGF, TGFB2), survival cytokines (MCP1, IL6, osteoprotegrin, follistatin, FLRG), and PIGS2 (COX2) were up-regulated. For some of the genes, these findings were validated by RT-PCR in vitro (Figure 4 ). In addition, 203 genes were down-regulated (Table 2) in CAFs compared to skin fibroblasts (fold change 42, Po0.05). These genes included many extracellular matrix and adhesion molecules, but not growth factors or cytokines. In all, 18 genes were up-regulated in CAFs compared to liver fibroblasts away from tumor, including PIGS2 (COX2) and TGFB2 (fold change 42, Po0.05), while 14 were down-regulated (fold change 42, Po0.05), shown in Table 3 .
Immunohistochemistry
To correlate the findings from the microarray and RT-PCR analyses that reflect transcript levels with protein Figure 1 Immunofluorescence detection of aSMA in primary fibroblasts from skin, normal liver, and metastatic colon cancer in the liver (CAF). The cells were fixed in cold methanol and stained with FITC-conjugated anti-aSMA antibody. All fibroblasts derived from three sources (cancer, normal liver, and skin) showed positive immunofluorescence, confirming that they were myofibroblasts Cancer-associated stromal fibroblasts H Nakagawa et al levels in vivo, we performed immunohistochemistry for SMA, COX2, and TGFb2 on 10 paraffin-embedded livers with metastatic colorectal cancer and 10 cirrhotic livers as controls for fibrosis without metastasis. Smooth muscle actin, a myofibroblast marker, strongly stained both cancer stromal fibroblasts and fibroblasts in cirrhotic livers (Figure 5a and b). All metastatic cancers but one stained positively with COX2. Of those nine cases, three showed COX2 immunoreactivity in CAF. The COX2 staining was focal in the cytoplasm of the cells (Figure 5c ). Fibroblasts in all 10 cirrhotic livers were negative for COX2 (Figure 5d ). TGFb2 was expressed in the CAFs as well as in the tumor cells and was not expressed in fibroblasts of cirrhotic livers (Figure 5e and f).
Discussion
We focused on the CAFs to understand the role and contribution of cancer stroma to cancer progression and metastasis, and generated their expression profiles using microarray analysis. To characterize the features of the CAFs, we showed by conditioned-medium proliferation assays that CAF-derived medium promoted cancer cell proliferation to a greater extent than other fibroblastderived medium, likely by secreting more growthpromoting factors (Gleave et al., 1991) . Irrespective of the origin of fibroblasts, previous reports have shown that fibroblasts enhance the growth of cancer cells and are often required to establish tumor by providing a feeding layer (Brattain et al., 1982; Picard et al., 1986; Camps et al., 1990; Gleave et al., 1991) . In our conditioned-medium assays, without direct interaction between cancer cells and fibroblasts, we also observed a clear-cut enhancement of cancer cell growth by all fibroblasts. CAFs had the greatest effect, and there was a highly significant difference between the effect of CAFs and normal skin fibroblasts.
In addition to the biological aspects, we showed a distinct expression difference at the molecular level between CAFs and the other fibroblasts. In the clustering analysis based upon the molecular expression profiles, CAFs and skin fibroblasts were each clustered in a group, suggesting that they were each homogeneous The effect of fibroblast culture-derived conditioned media on colon cell proliferation. HCT116 cells were counted after 3 days' incubation in each conditioned medium. Results were indicated as fold change in cell number as compared to control medium. Values represent the means of four experiments and are shown as mean7s.d. Among the fibroblast conditioned media, the CAFs showed the strongest growth effect on cancer cells and it was significantly greater than that of skin fibroblasts (P ¼ 0.0138, two-tailed). (c) BrdU incorporation assay. After a pulse of BrdU in each culture, incorporated BrdU was detected by immunostaining. Values represent the mean % positive staining cells in four experiments and are shown as mean7s.d. Among the fibroblast conditioned media, CAFs showed the strongest growth effect on cancer cells and it was significantly greater than that of skin fibroblasts (P ¼ 0.0280, two-tailed) Cancer-associated stromal fibroblasts H Nakagawa et al populations, while fibroblasts from the liver away from the tumor showed a heterogeneous molecular expression profile. The liver tissue used to make the fibroblast cultures was far away from the tumor and it is very unlikely that cancer cells were present. The heterogeneous expression profiles of the liver fibroblasts away from tumor suggest that the presence of metastatic cancer in the liver may affect the whole liver by a paracrine effect. Some fibroblasts, even away from tumor, may show a molecular profile similar to CAFs, while others may show a more normal pattern.
There is controversy regarding the origin of CAFs in cancer and metastasis (Studeny et al. 2002) , but the traditional view is that CAFs in liver metastasis are recruited locally from resident precursor-like satellite cells (Powell et al., 1999) . Normal liver fibroblasts may have a similar origin, and this may help explain why the gene expression profile that we detected was similar in CAFs and liver fibroblasts away from tumor. However, we did find some differences in their expression profiles. Some important genes were differentially expressed between CAFs and fibroblasts from normal liver, including PIGS2 (COX2) and TGFB2. Additionally, we validated COX2 and TGFB2 protein expression in vivo in CAFs of metastatic cancer in the liver. Both PIGS2 (COX2) and TGFB2 are thought to have an important role in the cancer microenvironment (Arteaga et al., 1993; Oshima et al., 1996; Williams et al., 2000; Derynck et al., 2001) .
In this study, the difference between CAFs and skin fibroblasts was more apparent than that of CAFs versus fibroblasts from normal liver away from tumor both in biological aspects and in gene expression patterns. To help understand the difference between CAFs and uninvolved fibroblasts and to further evaluate the role of CAFs, we compared their genome-wide expression profiles. We detected many adhesion molecules and extracellular matrix/extracellular matrix remodeling genes that were up-regulated in CAFs as compared to skin fibroblasts. Up-regulation of these genes supports the view that cancer stroma provides a favorable microenvironment for cancer cells by remodeling extracellular matrix. Protease and protease inhibitors including PAI1, tPA, and tissue factor were also up-regulated and they have a role in extracellular matrix turnover and cancer invasion or angiogenesis. It has been reported that their loss in the host may suppress cancer growth and angiogenesis (Bajou et al., 1998) . We also detected several other angiogenesis-promoting factors (VEGF, COX2, VCAM1) that were up-regulated genes in CAFs, suggesting that CAFs may be involved in angiogenesis by crosstalking with cancer cells and endothelial cells. It has been shown that stromal fibroblasts supply many of the angiogenetic factors to the microenvironment of the healing wound and cancer (Fukumura et al., 1998) . As expected from the findings of our cell proliferation assays using conditioned media, we identified upregulated secreted factors and cytokines that have been shown to promote cancer cell growth and survival including PDGF (Westermark and Heldin, 1991), TGFB2 (Derynck et al., 2001) , FGF1 (Dignass et al., 1994) , IGF binding proteins (Miyakoshi et al., 2001) , MCP1 (Youngs et al., 1997) , IL-6 (Conze et al., 2001) , osteoprotegrin (Holen et al., 2002) , ICAM1 (Gho et al., 2001) , follistatin and its homologue FLRG (Bartholin et al. 2002) . Growth factors (e.g. PDGF, TGFB2) from CAFs can also act as autocrine factors stimulating CAFs themselves and promoting fibrosis and angiogenesis (Derynck et al., 2001) .
To provide a quantitative measure of the number and type of genes expressed differentially in CAFs and skin fibroblasts, we categorized 170 up-regulated and 203 Figure 3 Clustering analysis showed the three CAFs (1-3) clustered tightly into one group and the three skin fibroblasts (Sk fb 1-3) into another, suggesting that CAFs are homogenous and different from skin fibroblasts. Liver fibroblasts (Li fb 1-3) were more heterogeneous in their expression pattern. There are 4071 genes used in this cluster diagram and genes were filtered using the criteria that standard deviation across the samples 430 and the coefficient of variation across the samples 40.2 Cancer-associated stromal fibroblasts H Nakagawa et al Functional annotation was available for about 76% of the genes and some genes had multiple annotations. Our analysis focused on genes involved in cell-cell communication and microenvironment that have been hypothesized to be involved in cancer stroma function. For each selected molecular function or biological process category, we compared the ranks of the fold changes of the differentially expressed genes in that category with the remainder of the differentially expressed genes, to test whether the genes as a group in that category were upor down-regulated compared with the rest. The results are shown in Table 4 . We observed that genes characterized as growth factors (P ¼ 0.0025), or those related to cytokine activity (P ¼ 0.0002), blood coagulation (P ¼ 0.0017), response to wounding (P ¼ 0.0062), apoptosis (P ¼ 0.0193), and cell-cell adhesion (P ¼ 0.0399) categories were significantly up-regulated among the differentially expressed genes. Overall, our results suggest that CAFs produce more growth factors and molecules involved in cell-cell interaction and wound healing than normal skin fibroblasts and, therefore, CAFs can behave as activated myofibroblasts functioning in a 'wound that does not heal' (Dvorak, 1986) . By using biological and molecular expression analysis, we obtained evidence that CAFs in metastatic colorectal cancers enhance the growth of cancer cells, and CAFs may be essential in the establishment of cancer metastasis by altering the microenvironment and promoting the crosstalking of many autocrine/paracrine factors and cell adhesion molecules between cancer cells and stromal components. These findings suggest that the stromal fibroblasts or their products may be useful targets for the development of future therapeutic agents. Additional molecular and in vivo studies are warranted to further evaluate the identified up-and/or down-regulated genes in metastatic colorectal carcinoma to the liver.
Materials and methods
Establishment of fibroblast cultures from fresh surgical specimen
We obtained fresh surgical specimens from three patients with metastatic colorectal cancers in the liver with approval by the IRB from The Ohio State University James Cancer Hospital. Primary fibroblast cultures of three types were established from each patient including, CAFs, normal liver fibroblasts away from the tumor, and normal skin fibroblasts from the incision site by the explant technique (Neaud et al., 1997) . The tissue was minced into 2-3 mm fragments and planted into the culture medium. The fibroblasts were cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco-BRL), containing 10% fetal bovine serum (FBS) and penicillin/streptomycin/ amphotericin B (Gibco-BRL). After five passages, cells in confluence were harvested for RNA extraction and the cultures were used to make conditioned medium.
Conditioned-medium cell proliferation assay
The fibroblast cultures were grown to confluence in DMEM containing 10% FBS, washed twice with PBS and twice with DMEM containing 1% FBS, and then incubated for 48 h in DMEM containing 1% FBS. The conditioned medium was collected, centrifuged for 15 min at 300 g to remove cell debris, sterile filtered and stored at À801C until use. Colon cancer cell line HCT116 was plated in 24-well plates and incubated for 3 days in conditioned medium and control medium containing 1% FBS. After incubation, living cells were counted using Figure 4 Validation of the microarray data by semiquantitive RT-PCR. Expression levels of growth factors and growthpromoting cytokines were analyzed in nine primary fibroblasts RNA (C: CAFs, Li: normal liver fibroblasts, Sk: skin fibroblasts). GAPDH was the reference gene Cancer-associated stromal fibroblasts H Nakagawa et al Trypan Blue staining (Gibco-BRL). BrdU incorporation was determined as described previously (DeGregori et al., 1995) . Briefly, after 24 h incubation in each medium, 10 mM BrdU (Sigma) was pulsed for 3 h followed by fixation with cold 50% methanol and 50% acetone. Incorporated BrdU was detected by anti-BrdU mouse antibody (Oncogene) and Rhodamineconjugated second goat antibody against mouse IgG (Pierce). At least 300 DAPI counter-stained nuclei were counted. These experiments were repeated four times as replicate culture dishes in the same experiments and the median of cell number was analysed by a t-test (two-tailed).
Microarray analysis
Total RNA was extracted from fibroblast cultures, cRNA was prepared from total RNA, and hybridized to HG-U133A Affymetrix oligonucleotide arrays containing probes to more than 22 000 human genes. Experimental procedures for GeneChip microarray were performed according to the Affymetrix GeneChip Expression Analysis as described previously (Virtaneva et al., 2001) . In brief, 8 mg of total RNA was used to synthesize double-stranded cDNA (Superscript Choice System/Gibco BRL). In vitro transcription was performed to produce biotin-labeled cRNA by using a BioArray HighYield RNA Transcription Labeling Kit (Enzo Diagnostics) according to the manufacturer's instructions. Biotinylated cRNA was cleaned with an RNeasy Mini Kit (Qiagen), fragmented to 50-200 nucleotides, and hybridized for 16 h at 451C to Affymetrix HG-U133A arrays. After being washed, the arrays were stained with streptavidin-phycoerythrin (Molecular Probes). Staining signal was amplified by biotinylated anti-streptavidin (Vector Laboratories) and by a second staining with streptavidin-phycoerythrin, and then scanned on a Hewlett-Packard GeneArray Scanner.
Statistical analysis
Scanned Affymetrix microarrays were analysed with dChip software (http://www.dchip.org) to obtain model-based gene expression estimates (Li and Wong, 2001 ). Cluster analysis was performed and viewed using CLUSTER and TREEVIEW software (Eisen et al., 1998) . To identify differentially expressed genes between any two different tissue types (e.g. CAFS vs skin fibroblast), two-sample t-test and the fold change between the means of two tissue samples were performed for each gene. We considered a gene to be differentially expressed between two tissues if the P-value o0.05 and it had a fold change over 2 with an absolute mean difference between the two tissues over 100. An analysis based on molecular function and biological process categories was performed for the set of differentially expressed genes to compare CAFs with skin fibroblasts. We used the Gene Ontology (GO) annotations, compiled by GO Consortium (Hill et al., 2002 ; http://www.geneontology.org). These annotations were retrieved from SOURCE database (http:// source.stanford.edu) that provides functional annotations, ontologies, and gene expression data (Diehn et al., 2003) . UniGene Cluster IDs of Affymetrix probe sets were used to identify GO annotations for each probe set. Probe sets with no information for their UniGene cluster IDs in SOURCE were checked using the gene name on GO database. For a selective set of molecular functions ('cell adhesion molecule', 'growth factor', 'cytokine activity') and biological processes ('blood coagulation', 'response to wounding', 'mitosis', 'blood vessel development', 'apoptosis', 'cell-cell adhesion', 'cell motility'), GO network structures were studied thoroughly using ontology information files 'function.ontology' and 'process.ontology' given in the GO database to identify all the genes belonging to these categories. A two-sided Wilcoxin rank-sum test was then performed to compare the ranks of the fold changes of the genes that belong to a category with the ranks of the fold changes of the remainder of the differentially expressed genes (Virtaneva et al., 2001) . A category with significant P-value indicates a systemic shift of fold changes of the genes that belong to that category, to the up-or downregulated groups.
Semiquantitative RT-PCR
In all, 2 mg total RNA was treated with Superscript II (Gibco BRL) to produce cDNA, using random hexamers according to 
Immunohistochemistry
A total of 10 metastatic colorectal cancers in the liver and 10 cirrhotic livers without tumor were selected for immunohistochemical study of SMA and the selected up-regulated molecules, cyclooxygenase-2 (COX2) and transforming growth factor b2 (TGFb2), which were identified as significantly up-regulated in the CAFs compared with skin fibroblasts and liver fibroblasts away from tumor (Tables 1 and 3) . Cirrhotic livers were chosen as controls rather than normal livers because normal livers have insufficient fibrosis and myofibroblastic stroma to compare with the CAFs. Paraffin-embedded tissue was cut at 4 mm and placed on positively charged slides. Slides were then placed in a 601C oven for 1 h, cooled, deparaffinized, and rehydrated through xylenes and graded alcohols to water. All slides were quenched for 5 min in a 3% hydrogen peroxide solution in water to block for endogenous peroxidase. Antigen retrieval was performed by incubating the slides with 1% sodium dodecyl sulfate for 5 min prior to incubation with primary antibody. Slides were then placed on the Dako Autostainer, immunostaining system, for use with immunohistochemistry. The primary antibody (aSMA, 1 : 75, Dako, Carpinteria, CA, USA; COX2, 1 : 100, Cayman, Ann Arbor, MI, USA; TGFb2, 1 : 100, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) was incubated for 1 h at room temperature. The detection system used was a labeled streptavidin-biotin complex (lsab2 from Dako). This method is based on the consecutive application of (1) a primary antibody against the antigen to be localized, (2) biotinylated link antibody, (3) enzymeconjugated streptavidin, and (4) substrate chromogen (DAB from Dako). The tissue was blocked with avidin/biotin blocking system (Dako) after application of the primary and before secondary application. Slides were then counterstained in Richard Allen hematoxylin, dehydrated through graded alcohols and coverslipped. The negative control was isotype immunoglobulin in place of the primary antibody. Positive and negative controls stained appropriately. 
